Biomarkers
GLP-1 Agonists in Psychiatry: A new perspective
Obesity and type 2 diabetes mellitus (T2DM) are two of the most pressing dangers to public health facing the United States today. This should come as no surprise, as these interrelated conditions have been affecting an ever-growing number of Americans for several decades. One piece of good news has been the development of medicines such […]
Is Integrative Psychiatry Going Mainstream?
As seen in Psychology Today. As a practitioner of mental health with an integrative approach to psychiatric treatment for over 25 years, the American Psychiatric Association’s Annual Meeting last week in San Francisco felt a bit like vindication. There is no doubt a growing acknowledgment within psychiatry that psychiatric conditions are not merely psychological or […]
The Road to Better Mental Health Passes Through the Gut
As seen in Psychology Today. Psychiatry has undergone several major evolutions over the last century. We’ve gone from a primarily psychoanalytic approach centered on talk therapies to a more neurobiological approach that pairs psychotherapies with medications capable of targeting specific neurotransmitters in the brain. Both modalities, psychotherapy and psychopharmacology, rose to prominence rapidly and disrupted […]
